![](https://investorshub.advfn.com/uicon/102211.png?cb=1719302007)
Wednesday, April 07, 2010 2:59:22 PM
http://pipeline.corante.com/archives/2010/04/07/generex_and_their_insulin_spray_just_hype.php
On boards like this (and AGEN would be another example)Feuerstein gets a bad press.
I think that's because people don't like to suffer from buyer's remorse, and therefore cognitive dissonance takes a firm lead over rational thought.
And someone will always pull up the odd occasion when he's been wrong.
But the fact of the matter is that he's far more often right than wrong. In fact, look at AGEN. Look at DSCO. Look at ABPI.
And he seems to be right about Generex and its Indian approval too.
Which makes me wonder why everyone wants to discount his views on HDVY:
http://www.thestreet.com/story/10683805/1/biotech-stock-mailbag-health-discovery.html
Recent HDVY News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 07:10:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2023 09:13:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/05/2023 07:53:39 PM
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM